MILESTONE SCIENTIFIC INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Milestone Scientific Inc. | |
|---|---|
| By: | /s/ Eric Hines |
| Chief Executive Officer and Principal Executive Officer | |
| /s/ Keisha Harcum | |
| Vice President of Finance and Principal Accounting Officer | |
Date: March 31, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Date | Title |
|---|---|---|
| /s/ Eric Hines | March 31, 2026 | Chief Executive Officer, Principal Executive Officer and Director |
| Eric Hines | ||
| /s/ Benedetta Casamento | March 31, 2026 | Chairman of the Board |
| Benedetta Casamento | ||
| /s/ Neal Goldman | March 31, 2026 | Director |
| Neal Goldman | ||
| /s/ Shanth Thiyagalingam | March 31, 2026 | Director |
| Shanth Thiyagalingam | ||
| /s/ Dr. Didier Demesmin | March 31, 2026 | Director |
| Dr. Didier Demesmin | ||
| /s/ Dr. Dawood Sayed | March 31, 2026 | Director |
| Dr. Dawood Sayed | ||
REPORT INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
For the Years Ended December 31, 2025 and 2024
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 199) | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 688) | F-3 |
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations | F-5 |
| Consolidated Statements of Changes in Stockholders’ Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 -F-24 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.